CORT Financial Facts

Research and development: 5.67M
Loss from operations: 1.51M
See Full Income Statement

Total current liabilities: 27.43M
Total current assets: 54.78M
See Full Balance Sheet

Corcept Therapeutics (CORT) Earnings

  |   Expand Research on CORT
Next EPS Date 11/7/16 *Est. EPS Growth Rate +250.0% *Last Qtr.
Average EPS % Beat Rate +125.0% Revenue Growth Rate +64.2% *Last Qtr.
Average % Move 1-Wk after EPS +9.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/2/16 Q216 $0.03$0.01 +$0.02$19.7M$18.36M = Details
5/3/16 Q116 $0.02$0.01 +$0.01$16.1M$16.32M = Details
1/28/16 Q415 $0.01-$0.02 +$0.03$15M$15.5M = Details
11/5/15 Q315 -$0.01-$0.02 +$0.01$13.3M$13.9M N/A Details
8/5/15 Q215 -$0.02-$0.04 +$0.02$12M$11.67M N/A Details
5/7/15 Q115 -$0.05-$0.04 -$0.01$10.1M$10.5M N/A Details
3/4/15 Q414 -$0.02-$0.06 +$0.04$9.01M$9.1M N/A Details
11/4/14 Q214 N/A-$0.07 N/A N/A$7.62M N/A N/A N/A